PAK4 overexpression has been shown to promote ovarian cancer cell migration and invasion in a c-Src and MEK-1 kinase-dependent manner, and induce cell proliferation through the Pak4/c-Src/EGFR (epidermal growth factor receptor) pathway [19]. Here, SRC is linked to ovarian cancer.